Ligand Pharmaceuticals | LGND - Mitarbeiter Gesamtzahl





Mitarbeiter Veränderung Datum
Agenus 389 144 2023-12
Amgen 28K 1.3K 2024-12
Anika Therapeutics 357 12 2023-12
Arrowhead Research 711 102 2025-12
Baxter International 38K 22K 2024-12
Bristol-Myers Squibb 34.1K 0 2024-12
Eli Lilly 47K 4K 2024-12
Enanta Pharmaceuticals 145 15 2023-09
Enviri Corporation 13K 1000 2023-12
Gilead Sciences 17.6K 400 2024-12
GlaxoSmithKline 69.4K 20.7K 2022-12
Glaxosmithkline GBP 69.4K 20.7K 2022-12
Heron Therapeutics 126 77 2023-12
Insmed 1.27K 359 2024-12
Intrexon 202 7 2023-12
Ionis Pharmaceuticals 1.07K 142 2024-12
Karyopharm Therapeutics 325 60 2023-12
Ligand Pharmaceuticals 68 10 2024-12
MacroGenics 339 18 2023-12
Merck 75K 3K 2024-12
Pacira 790 79 2024-12
Pfizer 81K 7K 2024-12
Rigel Pharmaceuticals 147 8 2023-12
Sangamo BioSciences 405 73 2023-12
Veracyte 824 9 2024-12